Prevalence and incidence of acute and chronic comorbidity in patients with squamous cell carcinoma of the head and neck

Head and Neck

Volumn 34, Issue 2, 2012, Pages 238-244

  Landis, Sarah H ^a   El Hariry, Iman A ^a   Van Herk Sukel, Myrthe P P ^b   Van Den Haak, Pieter ^b   Janssen Heijnen, Maryska L G ^c   Penning Van Beest, Fernie J A ^b   Herings, Ron M C ^b,d  

^a GLAXOSMITHKLINE   (United Kingdom)

^b PHARMO INSTITUTE FOR DRUG OUTCOMES RESEARCH   (Netherlands)

^c The Netherlands   (Netherlands)

^d ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

chemotherapy; comorbidity; incidence; prevalence; squamous cell head and neck cancer

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; ANEMIA; ARTICLE; ASTHMA; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER RADIOTHERAPY; CANCER SURGERY; CARDIOVASCULAR DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; CONTROLLED STUDY; DEPRESSION; DIABETES MELLITUS; FEMALE; HEAD AND NECK CARCINOMA; HUMAN; MAJOR CLINICAL STUDY; MALE; PNEUMONIA; PREVALENCE; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; SQUAMOUS CELL CARCINOMA; SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK;

AGED; CARCINOMA, SQUAMOUS CELL; CARDIOVASCULAR DISEASES; COMORBIDITY; DEPRESSION; DIABETES MELLITUS; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PRECANCEROUS CONDITIONS; PREVALENCE; RESPIRATORY TRACT DISEASES;

EID: 84855691761     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.21720     Document Type: Article

References (32)

1. Ferlay J, Shin H, Bray F, Froman D, Mathers C, Parkin D,. GLOBOCAN 2008, Cancer incidence and mortality worldwide: IARC Cancer Base No. 10. International Agency for Research on Cancer 2010.
2. Ernster JA, Sciotto CG, O'Brien MM, et al. Rising incidence of oropharyngeal cancer and the role of oncogenic human papillomavirus. Laryngoscope 2007; 117: 2115-2128. (Pubitemid 351339584)
3. Gillison ML, Koch WM, Capone RB, et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst 2000; 92: 709-720. (Pubitemid 30365531)
4. Sturgis EM, Cinciripini PM,. Trends in head and neck cancer incidence in relation to smoking prevalence: an emerging epidemic of human papillomavirus-associated cancers? Cancer 2007; 110: 1429-1435. (Pubitemid 47463055)
5. Castellsague X, Quintana MJ, Martinez MC, et al. The role of type of tobacco and type of alcoholic beverage in oral carcinogenesis. Int J Cancer 2004; 108: 741-749. (Pubitemid 38076406)
6. van der Schroeff MP, van de Schans SA, Piccirillo JF, Langeveld TP, Baatenburg de Jong RJ, Janssen-Heijnen ML,. Conditional relative survival in head and neck squamous cell carcinoma: permanent excess mortality risk for long-term survivors. Head Neck 2010; 32: 1613-1618.
7. Haddad R, Allen A, Wirth L, Tishler R, Posner M,. Integrating novel agents into the curative treatment of head and neck cancer. Expert Rev Anticancer Ther 2006; 6: 157-159. (Pubitemid 44192927)
8. Paleri V, Narayan R, Wight RG,. Descriptive study of the type and severity of decompensation caused by comorbidity in a population of patients with laryngeal squamous cancer. J Laryngol Otol 2004; 118: 517-521. (Pubitemid 39061784)
9. Terrell JE, Nanavati K, Esclamado RM, Bradford CR, Wolf GT,. Health impact of head and neck cancer. Otolaryngol Head Neck Surg 1999; 120: 852-859. (Pubitemid 29269718)
10. Alho OP, Hannula K, Luokkala A, Teppo H, Koivunen P, Kantola S,. Differential prognostic impact of comorbidity in head and neck cancer. Head Neck 2007; 29: 913-918.
11. Chen AY, Matson LK, Roberts D, Goepfert H,. The significance of comorbidity in advanced laryngeal cancer. Head Neck 2001; 23: 566-572. (Pubitemid 32565530)
12. Ferrier MB, Spuesens EB, Le CS, Baatenburg de Jong RJ,. Comorbidity as a major risk factor for mortality and complications in head and neck surgery. Arch Otolaryngol Head Neck Surg 2005; 131: 27-32. (Pubitemid 40105457)
13. Montero EH, Trufero JM, Romeo JA, Terre FC,. Comorbidity and prognosis in advanced hypopharyngeal-laryngeal cancer under combined therapy. Tumori 2008; 94: 24-29. (Pubitemid 351487181)
14. Yung KC, Piccirillo JF,. The incidence and impact of comorbidity diagnosed after the onset of head and neck cancer. Arch Otolaryngol Head Neck Surg 2008; 134: 1045-1049.
15. Teppo H, Alho OP,. Comorbidity and diagnostic delay in cancer of the larynx, tongue and pharynx. Oral Oncol 2009; 45: 692-695.
16. Herings RM, Bakker A, Stricker BH, Nap G,. Pharmaco-morbidity linkage: a feasibility study comparing morbidity in two pharmacy based exposure cohorts. J Epidemiol Community Health 1992; 46: 136-140.
17. Stricker BH, Herings RM, Bakker A, Valkenburg HA, Sturmans F,. Pharmaco-morbidity linking: a potential instrument for post-marketing surveillance. Ned Tijdschr Geneeskd 1990; 134: 1886-1889. (Pubitemid 20332389)
18. van Herk-Sukel MP, van de Poll-Franse LV, Lemmens VE, et al. New opportunities for drug outcomes research in cancer patients: the linkage of the Eindhoven Cancer Registry and the PHARMO Record Linkage System. Eur J Cancer 2010; 46: 395-404.
19. FMWV (Federation of Medical Research Associations). Code Goed Gedrag. Gedragscode Gezondheidsonderzoek. 2005.
20. Breslow NE, Day NE,. Statistical methods in cancer research. Volume II: The design and analysis of cohort studies. Lyon, France: IARC Scientific Publications; 1989. pp 69-72.
21. Nederlandse Werkgroep Hoofd-Halstumoren. Mondholte-En orofarynxcarcinoom: Landelijke richtlijn, Versie 1.4. 2004.
22. Piccirillo JF, Vlahiotis A,. Comorbidity in patients with cancer of the head and neck: prevalence and impact on treatment and prognosis. Curr Oncol Rep 2006; 8: 123-129.
23. Buitelaar DR, Balm AJ, Antonini N, van Tinteren H, Huitink JM,. Cardiovascular and respiratory complications after major head and neck surgery. Head Neck 2006; 28: 595-602. (Pubitemid 44025107)
24. Manzoor T, Ahmed Z, Sheikh NA, Khan MM,. Pulmonary complications associated with head and neck cancer surgery. J Coll Physicians Surg Pak 2007; 17: 558-561.
25. Nouraei SA, Al-Yaghchi C, Sandhu GS, Giussani DA, Doyle P, Clarke PM,. Incidence and significance of myocardial injury after surgical treatment of head and neck cancer. Laryngoscope 2007; 117: 1581-1587. (Pubitemid 47357386)
26. Humphris GM, Rogers S, McNally D, Lee-Jones C, Brown J, Vaughan D,. Fear of recurrence and possible cases of anxiety and depression in orofacial cancer patients. Int J Oral Maxillofac Surg 2003; 32: 486-491. (Pubitemid 38263347)
27. Hammerlid E, Ahlner-Elmqvist M, Bjordal K, et al. A prospective multicentre study in Sweden and Norway of mental distress and psychiatric morbidity in head and neck cancer patients. Br J Cancer 1999; 80: 766-774. (Pubitemid 29209839)
28. Gritz ER, Schacherer C, Koehly L, Nielsen IR, Abemayor E,. Smoking withdrawal and relapse in head and neck cancer patients. Head Neck 1999; 21: 420-427. (Pubitemid 29354897)
29. van Bokhorst-de van der Schueren MA, van Leeuwen PA, Sauerwein HP, Kuik DJ, Snow GB, Quak JJ,. Assessment of malnutrition parameters in head and neck cancer and their relation to postoperative complications. Head Neck 1997; 19: 419-425. (Pubitemid 27293225)
30. Schwartz LH, Ozsahin M, Zhang GN, et al. Synchronous and metachronous head and neck carcinomas. Cancer 1994; 74: 1933-1938. (Pubitemid 24301857)
31. Castro MA, Dedivitis RA, Ribeiro KC,. Comorbidity measurement in patients with laryngeal squamous cell carcinoma. ORL J Otorhinolaryngol Relat Spec 2007; 69: 146-152. (Pubitemid 46597289)
32. Harandi A, Zaidi AS, Stocker AM, Laber DA,. Clinical efficacy and toxicity of anti-EGFR therapy in common cancers. J Oncol 2009; 2009: 567486.